Your session is about to expire
← Back to Search
Digital Tool for Elderly Patients with Cancer
N/A
Waitlist Available
Led By Kah Poh Loh
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week
Awards & highlights
Study Summary
This trialtests if a digital tool for elderly cancer patients and their caregivers is effective, gathering feedback from users and their medical teams to improve it.
Who is the study for?
This trial is for English-speaking cancer patients aged 65 or older, their caregivers, and oncology healthcare providers. Participants must be able to give informed consent and have a caregiver involved in their health matters.Check my eligibility
What is being tested?
The study is testing an electronic platform designed for geriatric assessment (eGAP) in older cancer patients. It aims to refine the tool based on feedback from patients, caregivers, and medical professionals.See study design
What are the potential side effects?
Since this trial involves a behavioral intervention with an electronic platform rather than medication, traditional physical side effects are not expected. However, users may experience difficulty using the technology or emotional responses to assessments.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility Retention Rate
Secondary outcome measures
Recruitment rates
Self-Report Completion Time
System Usability Scale
Trial Design
1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
The eGAP consists of validated questionnaires that are used to assess health status of older adults with cancer. Based on patient responses, tailored recommendations will be provided.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral
2018
Completed Phase 4
~1160
Find a Location
Who is running the clinical trial?
University of RochesterLead Sponsor
837 Previous Clinical Trials
518,102 Total Patients Enrolled
Kah Poh LohPrincipal InvestigatorUniversity of Rochester
5 Previous Clinical Trials
295 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You must be at least 21 years old.You understand the purpose and risks of the study and willingly agree to participate.You must speak English because the platform is only available in English.You must be able to speak English.The doctor, nurse practitioner, or nurse who takes care of you.You are 65 years old or older.You have been diagnosed with cancer.You have a family member, partner, friend, or caregiver who can help you with your health-related decisions.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is participation in this research study still open to individuals?
"Affirmative. Clinicaltrials.gov reveals that this research undertaking was initially posted on December 7th 2021 and is currently recruiting participants. The trial seeks to enlist 50 individuals from a single medical centre."
Answered by AI
How many participants can join this medical experiment?
"Affirmative, according to clinicaltrials.gov this research project is currently recruiting patients. The trial was first advertised on December 7th 2021 and the data was most recently refreshed on October 3rd 2022. A total of 50 individuals must be enrolled from one medical centre for completion of the study."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger